Form D Explorer

Form D — Latigo Biotherapeutics, Inc.

0002056611-25-000001 · filed Feb 13, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$149,999,990
Reported amount sold
$49,999,995
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Latigo Biotherapeutics, Inc.
CIK
2056611
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
1300 RANCHO CONEJO BLVD. SUITE 305
THOUSAND OAKS, CA 91320
Phone
805-716-2927

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗